Works matching IS 02692813 AND DT 2025 AND VI 61 AND IP 4

Results: 35

Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 714, doi. 10.1111/apt.18491
By:
- Hung, Yi‐Ping;
- Huang, Yi‐Hsiang
Publication type:
Article
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 737, doi. 10.1111/apt.18489
By:
- Akiyama, Shintaro;
- Fujii, Toshimitsu
Publication type:
Article
Letter: Identifying the Best Model for Predicting Post‐SVR HCC—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 750, doi. 10.1111/apt.18488
By:
- Shiha, Gamal;
- Soliman, Riham
Publication type:
Article
Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 706, doi. 10.1111/apt.18485
By:
- Taylor, Sarah;
- Chen, Lynna;
- Dutt, Krishneel;
- Boyapati, Ray;
- Ye, Bei;
- Ong, Sim;
- Kruavit, Anuk;
- Lee, Nora;
- Apostolov, Ross;
- Suleiman, Mani;
- Tacey, Mark;
- Ho, Prahlad;
- Gibson, Peter R.;
- Garg, Mayur
Publication type:
Article
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study: Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 743, doi. 10.1111/apt.18483
By:
- Shiha, Gamal;
- Soliman, Riham
Publication type:
Article
Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter? Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 733, doi. 10.1111/apt.18479
By:
- Chuah, Kee Huat;
- Loo, Qing Yuan;
- Hian, Wen Xuan;
- Khoo, Xin Hui;
- Panirsheeluam, Sarala;
- Jubri, Nurhidayah Binti Mohammad;
- Natarajan, Vicraman;
- Khoo, Stanley;
- Mahadeva, Sanjiv
Publication type:
Article
Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 628, doi. 10.1111/apt.18478
By:
- El‐Kassas, Mohamed;
- Mostafa, Hala;
- Abdellatif, Wessam;
- Shoman, Sohier;
- Esmat, Gamal;
- Brahmania, Mayur;
- Liu, Hongqun;
- Lee, Samuel S.
Publication type:
Article
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative Colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 735, doi. 10.1111/apt.18476
By:
- Woelfel, Simon;
- Brand, Stephan
Publication type:
Article
Editorial: Where to Start in Ulcerative Colitis?
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 739, doi. 10.1111/apt.18475
By:
- Lee, Tanya;
- Ding, Nik;
- Chetwood, John David
Publication type:
Article
Analysis of Antroduodenal Motility in Patients With Hypermobility Spectrum Disorders/Hypermobile Ehlers–Danlos Syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 702, doi. 10.1111/apt.18471
By:
- Sweerts, Kim W. E.;
- Mujagic, Zlatan;
- Keszthelyi, Daniel;
- Conchillo, José M.
Publication type:
Article
Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinaemia—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 729, doi. 10.1111/apt.18470
By:
- Amangurbanova, Maral;
- Loomba, Rohit
Publication type:
Article
The Proteomics of MASLD Progression: Insights From Functional Analysis to Drive the Development of New Therapeutic Solutions.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 614, doi. 10.1111/apt.18468
By:
- Pirola, Carlos José;
- Fernández Gianotti, Tomas;
- Sookoian, Silvia
Publication type:
Article
Correction to 'Editorial: Unravelling the fibres—low dietary fibre may lower risk of developing IBD'.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 752, doi. 10.1111/apt.18467
Publication type:
Article
Management of Perianal Fistulizing Crohn's Disease According to Principles of Wound Repair.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 600, doi. 10.1111/apt.18466
By:
- McCurdy, Jeffrey D.;
- Hartley, Imogen;
- Behrenbruch, Corina;
- Hart, Ailsa;
- Tozer, Phil;
- Ding, Nik S.
Publication type:
Article
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 721, doi. 10.1111/apt.18465
By:
- Wang, Jian;
- Zhang, Shaoqiu;
- Fan, Tao;
- Wu, Chao;
- Huang, Rui
Publication type:
Article
Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 746, doi. 10.1111/apt.18464
By:
- Carbery, Isabel;
- Todd, Oliver;
- Selinger, Christian P.
Publication type:
Article
Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care. Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 725, doi. 10.1111/apt.18461
By:
- Herta, Toni;
- Joachim‐Richter, Anna;
- Petroff, David;
- Wiegand, Johannes
Publication type:
Article
Editorial: Heads or Tails in the Treatment of Functional Dyspepsia—Does the Side of the Coin Matter?
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 731, doi. 10.1111/apt.18456
By:
- Van de Bruaene, Cedric;
- Vanuytsel, Tim
Publication type:
Article
Editorial: Striving for Equitable Care in Ulcerative Colitis—Authors' Reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 718, doi. 10.1111/apt.18454
By:
- McFalls, Caya;
- Melia, Joanna
Publication type:
Article
Editorial: Evaluating the Prevalence of Metabolic Dysfunction‐Associated Steatotic Liver Disease in Patients With Type 2 Diabetes and Hyperferritinemia.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 727, doi. 10.1111/apt.18453
By:
- Bhardwaj, Nakul J.;
- Kim, Rebecca G.
Publication type:
Article
Editorial: Hepatitis D Screening—DAS (Delta Virus Awareness and Screening) Approach in Primary Care.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 723, doi. 10.1111/apt.18446
By:
- Singh, Noreen;
- Ma, Mang
Publication type:
Article
Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 693, doi. 10.1111/apt.18441
By:
- Haynesworth, Austin;
- Yeh, Kuan‐Hung;
- Lee, Han Hee;
- Kirkpatrick, Melissa;
- Boland, Brigid S.;
- Syal, Gaurav;
- Xu, Ronghui;
- Singh, Siddharth
Publication type:
Article
Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 682, doi. 10.1111/apt.18438
By:
- Kilani, Yassine;
- Alsakarneh, Saqr;
- Madi, Mahmoud Y.;
- Mosquera, Daniel Alejandro Gonzalez;
- Ferreira, Mariana Nunes;
- Jaber, Fouad;
- Helzberg, John;
- Duong, Nikki;
- Syn, Wing‐Kin
Publication type:
Article
Letter: Identifying the Best Model for Predicting Post‐SVR HCC.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 748, doi. 10.1111/apt.18437
By:
- Toyoda, Hidenori
Publication type:
Article
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 719, doi. 10.1111/apt.18436
By:
- Hume, S. J.;
- Thompson, A. J.;
- Levy, M. T.
Publication type:
Article
Risk‐Adapted Starting Ages of Colorectal Cancer Screening for People With Diabetes or Metabolic Syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 675, doi. 10.1111/apt.18435
By:
- Seum, Teresa;
- Hoffmeister, Michael;
- Brenner, Hermann
Publication type:
Article
In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 667, doi. 10.1111/apt.18433
By:
- Ferrarese, Alberto;
- Zanaga, Paola;
- Battistella, Sara;
- Zanella, Silvia;
- Zappitelli, Teresa;
- Boldrin, Caterina;
- Pacenti, Monia;
- Cattai, Margherita;
- Bordignon, Greta;
- Gomiero, Federica;
- Epifani, Magdalena;
- Villano, Marco;
- Gambato, Martina;
- Zanetto, Alberto;
- Cazzagon, Nora;
- Chemello, Liliana;
- Pasin, Francesca;
- Calò, Lorenzo;
- Doria, Andrea;
- Trentin, Livio
Publication type:
Article
Leucine‐Rich Alpha‐2 Glycoprotein Is Associated With Transmural Inflammation Assessed by Intestinal Ultrasound in Patients With Crohn's Disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 658, doi. 10.1111/apt.18430
By:
- Komatsu, Moeko;
- Sagami, Shintaro;
- Hojo, Aya;
- Karashima, Ryo;
- Maeda, Masa;
- Yamana, Yoko;
- Serizawa, Kanade;
- Umeda, Satoko;
- Asonuma, Kunio;
- Nakano, Masaru;
- Hibi, Toshifumi;
- Matsuda, Takahisa;
- Kobayashi, Taku
Publication type:
Article
Letter: Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 744, doi. 10.1111/apt.18428
By:
- Dai, Cong;
- Huang, Yu‐Hong;
- Jiang, Min
Publication type:
Article
Letter: Prospective Individualised Validation of the GES in Predicting Hepatocellular Carcinoma—A 'Precision Medicine' Study.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 741, doi. 10.1111/apt.18425
By:
- Helmy, Ahmed
Publication type:
Article
Editorial: Striving for Equitable Care in Ulcerative Colitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 716, doi. 10.1111/apt.18423
By:
- Barnes, Edward L.
Publication type:
Article
Management of Patients With Refractory Reflux‐Like Symptoms Despite Proton Pump Inhibitor Therapy: Evidence‐Based Consensus Statements.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 636, doi. 10.1111/apt.18420
By:
- Armstrong, David;
- Hungin, A. Pali;
- Kahrilas, Peter J.;
- Sifrim, Daniel;
- Moayyedi, Paul;
- Vaezi, Michael F.;
- Al‐Awadhi, Sameer;
- Anvari, Sama;
- Bell, Reginald;
- Delaney, Brendan;
- Emura, Fabian;
- Gyawali, C. Prakash;
- Katelaris, Peter;
- Lazarescu, Adriana;
- Lee, Yeong Yeh;
- Repici, Alessandro;
- Roman, Sabine;
- Rooker, Ceciel T.;
- Savarino, Edoardo Vincenzo;
- Sinclair, Paul
Publication type:
Article
Editorial: High Baseline ALT Level Confers Risk of Hepatic Adverse Events During Immune Checkpoint Inhibitors Treatment: A Call for Caution.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 712, doi. 10.1111/apt.18422
By:
- Zhao, Ze‐Hua;
- Fan, Yu‐Chen
Publication type:
Article
Issue Information.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 597, doi. 10.1111/apt.18072
Publication type:
Article
Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting.
Published in:
Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 4, p. 651, doi. 10.1111/apt.18424
By:
- Herta, Toni;
- Joachim‐Richter, Anna;
- Petroff, David;
- Wölk, Benno;
- Wolffram, Ingmar;
- Berg, Thomas;
- Kramer, Jan;
- Bätz, Olaf;
- Wiegand, Johannes
Publication type:
Article